Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000405758

Medchemexpress LLC Ellagic acid | 476-66-4 | 1 G
SDP

Catalog No. 5000405758
Encompass_Preferred

Ellagic acid is a natural antioxidant that acts as a potent and ATP-competitive inhibitor of CK2 and SHP2, with an IC50 of 40 nM and a Ki of 20 nM. This compound also blocks other kinases such as LYN, PKA, SYK, GSK3, FGR, and CK1.

  • Acts as a natural antioxidant
  • Functions as a potent and ATP-competitive inhibitor of CK2 and SHP2
  • Blocks various other kinases including LYN, PKA, SYK, GSK3, FGR, and CK1
  • Exhibits inhibitory activities against Karpas299, SUDHL1, SR786, and FE-PD cell lines
  • Shows cytotoxic effects on MCF-7 cells after radiation treatment
  • Induces cell apoptosis in MCF-7 cells when combined with irradiation
  • Decreases MDA brain content and reduces brain TNF-α levels in rats
  • Increases brain contents of 5-HT, dopamine, and norepinephrine in rats
  • Reduces histopathological changes induced by Doxorubicin in rats
  • Supported by over 20 cited publications

Catalog No. 50-004-05758 Supplier Medchemexpress LLC Supplier No. HYB01831G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Ellagic acid is a natural antioxidant that acts as a potent and ATP-competitive inhibitor of CK2 and SHP2, with an IC50 of 40 nM and a Ki of 20 nM. This compound also blocks other kinases such as LYN, PKA, SYK, GSK3, FGR, and CK1.

  • Acts as a natural antioxidant
  • Functions as a potent and ATP-competitive inhibitor of CK2 and SHP2
  • Blocks various other kinases including LYN, PKA, SYK, GSK3, FGR, and CK1
  • Exhibits inhibitory activities against Karpas299, SUDHL1, SR786, and FE-PD cell lines
  • Shows cytotoxic effects on MCF-7 cells after radiation treatment
  • Induces cell apoptosis in MCF-7 cells when combined with irradiation
  • Decreases MDA brain content and reduces brain TNF-α levels in rats
  • Increases brain contents of 5-HT, dopamine, and norepinephrine in rats
  • Reduces histopathological changes induced by Doxorubicin in rats
  • Supported by over 20 cited publications

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.